These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1568570)

  • 1. Effects of nonsteroidal anti-inflammatory drugs and misoprostol on gastroduodenal epithelial proliferation in arthritis.
    Levi S; Goodlad RA; Lee CY; Walport MJ; Wright NA; Hodgson HJ
    Gastroenterology; 1992 May; 102(5):1605-11. PubMed ID: 1568570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study of the safety/efficacy of misoprostol in the prevention and treatment of NSAID-induced gastroduodenal lesions.
    Grazioli I; Avossa M; Bogliolo A; Broggini M; Carcassi A; Carcassi U; Cecconami L; Ligniere GC; Colombo B; Consoli G
    Clin Exp Rheumatol; 1993; 11(3):289-94. PubMed ID: 8353983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials.
    Leandro G; Pilotto A; Franceschi M; Bertin T; Lichino E; Di Mario F
    Dig Dis Sci; 2001 Sep; 46(9):1924-36. PubMed ID: 11575445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Misoprostol Study Group.
    Graham DY; White RH; Moreland LW; Schubert TT; Katz R; Jaszewski R; Tindall E; Triadafilopoulos G; Stromatt SC; Teoh LS
    Ann Intern Med; 1993 Aug; 119(4):257-62. PubMed ID: 8328732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori infection, ABO blood group, and effect of misoprostol on gastroduodenal mucosa in NSAID-treated patients with rheumatoid arthritis.
    Henriksson K; Uribe A; Sandstedt B; Nord CE
    Dig Dis Sci; 1993 Sep; 38(9):1688-96. PubMed ID: 8359082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
    Geis GS; Stead H; Wallemark CB; Nicholson PA
    J Rheumatol Suppl; 1991 Mar; 28():11-4. PubMed ID: 1903808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis.
    Stalnikowicz R; Rachmilewitz D
    J Clin Gastroenterol; 1993 Oct; 17(3):238-43. PubMed ID: 7901267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventive efficacy and safety of rebamipide in nonsteroidal anti-inflammatory drug-induced mucosal toxicity.
    Kim JH; Park SH; Cho CS; Lee ST; Yoo WH; Kim SK; Kang YM; Rew JS; Park YW; Lee SK; Lee YC; Park W; Lee DH
    Gut Liver; 2014 Jul; 8(4):371-9. PubMed ID: 25071901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
    Delmas PD; Lambert R; Capron MH
    Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of longterm misoprostol coadministration with non-steroidal anti-inflammatory drugs: a histological study.
    Shah K; Price AB; Talbot IC; Bardhan KD; Fenn CG; Bjarnason I
    Gut; 1995 Aug; 37(2):195-8. PubMed ID: 7557567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol.
    Lee KN; Lee OY; Choi MG; Choi SR; Lee DH; Lee YC; Kim TN; Choi SC; Rew JS; Seol SY
    J Korean Med Sci; 2011 Aug; 26(8):1074-80. PubMed ID: 21860559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN; Smith JL; Lidsky MD; Graham DY
    Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing.
    Levi S; Goodlad RA; Lee CY; Stamp G; Walport MJ; Wright NA; Hodgson HJ
    Lancet; 1990 Oct; 336(8719):840-3. PubMed ID: 1699093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of the gastroduodenal mucosa from the effects of diclofenac sodium: role of highly selective vagotomy and misoprostol.
    Giannoukas AD; Baltoyiannis G; Milonakis M; Nastos D; Papagikos L; Kappas AM; Fatouros M; Papadimitriou C; Cassioumis D
    World J Surg; 1996 May; 20(4):501-5 discussion 505-6. PubMed ID: 8662142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM; Saggioro A
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
    Raskin JB; White RH; Jackson JE; Weaver AL; Tindall EA; Lies RB; Stanton DS
    Ann Intern Med; 1995 Sep; 123(5):344-50. PubMed ID: 7625622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased gastric juice epidermal growth factor after non-steroidal anti-inflammatory drug ingestion.
    Kelly SM; Jenner JR; Dickinson RJ; Hunter JO
    Gut; 1994 May; 35(5):611-4. PubMed ID: 8200552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.